End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.38 CNY | +1.70% | +1.82% | -17.76% |
Apr. 24 | Beijing SL Pharmaceutical Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
Apr. 23 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 1.18B 163M | Sales 2025 * | 1.37B 190M | Capitalization | 8.61B 1.19B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 7.27 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 6.27 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 757 |
Yield 2024 * |
1.79% | Yield 2025 * |
1.91% | Free-Float | 57.71% |
1 day | +1.70% | ||
1 week | +1.82% | ||
Current month | -4.77% | ||
1 month | -4.23% | ||
3 months | -5.52% | ||
6 months | -29.76% | ||
Current year | -17.76% |
Managers | Title | Age | Since |
---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 60 | 06-06-10 |
Li Ji
DFI | Director of Finance/CFO | 43 | 23-04-23 |
Shu Jie Liang
BRD | Director/Board Member | 58 | 06-04-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 60 | 06-06-10 |
Shu Jie Liang
BRD | Director/Board Member | 58 | 06-04-10 |
Yu Lin Chen
BRD | Director/Board Member | 79 | 06-04-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.11% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.38 | +1.70% | 14,837,240 |
24-04-25 | 8.24 | +3.13% | 19,567,000 |
24-04-24 | 7.99 | -4.65% | 29,305,410 |
24-04-23 | 8.38 | +0.84% | 11,536,060 |
24-04-22 | 8.31 | +0.97% | 10,390,600 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.76% | 1.19B | |
+25.83% | 661B | |
+26.83% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.89% | 231B | |
+5.28% | 200B | |
-8.83% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 002038 Stock